Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Translational Neurodegeneration
Published in: Translational Neurodegeneration 1/2016

Open Access 01-12-2016 | Review

The study of brain functional connectivity in Parkinson’s disease

Authors: Lin-lin Gao, Tao Wu

Published in: Translational Neurodegeneration | Issue 1/2016

Login to get access

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder primarily affecting the aging population. The neurophysiological mechanisms underlying parkinsonian symptoms remain unclear. PD affects extensive neural networks and a more thorough understanding of network disruption will help bridge the gap between known pathological changes and observed clinical presentations in PD. Development of neuroimaging techniques, especially functional magnetic resonance imaging, allows for detection of the functional connectivity of neural networks in patients with PD. This review aims to provide an overview of current research involving functional network disruption in PD relating to motor and non-motor symptoms. Investigations into functional network connectivity will further our understanding of the mechanisms underlying the effectiveness of clinical interventions, such as levodopa and deep brain stimulation treatment. In addition, identification of PD-specific neural network patterns has the potential to aid in the development of a definitive diagnosis of PD.
Literature
1.
Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368–76.CrossRefPubMed
2.
DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol. 2007;64:20–4.CrossRefPubMed
3.
Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci. 2007;8:700–11.CrossRefPubMed
4.
Wu T, Long X, Zang Y, Wang L, Hallett M, Li K, Chan P. Regional homogeneity changes in patients with Parkinson’s disease. Hum Brain Mapp. 2009;30:1502–10.CrossRefPubMed
5.
Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A. 1990;87:9868–72.CrossRefPubMedPubMedCentral
6.
Sporns O, Chialvo DR, Kaiser M, Hilgetag CC. Organization, development and function of complex brain networks. Trends Cogn Sci. 2004;8:418–25.CrossRefPubMed
7.
8.
Stam CJ. Characterization of anatomical and functional connectivity in the brain: a complex networks perspective. Int J Psychophysiol. 2010;77:186–94.CrossRefPubMed
9.
Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10:186–98.CrossRefPubMed
10.
11.
Friston K. Functional and effective connectivity in neuroimaging: A synthesis [J]. Hum Brain Mapp. 1994;2:56–78.CrossRef
12.
Wu T, Wang L, Hallett M, Chen Y, Li K, Chan P. Effective connectivity of brain networks during self-initiated movement in Parkinson’s disease. Neuroimage. 2011;55:204–15.CrossRefPubMed
13.
Rowe J, Stephan KE, Friston K, Frackowiak R, Lees A, Passingham R. Attention to action in Parkinson’s disease: impaired effective connectivity among frontal cortical regions. Brain. 2002;125:276–89.CrossRefPubMed
14.
Wu T, Chan P, Hallett M. Effective connectivity of neural networks in automatic movements in Parkinson’s disease. Neuroimage. 2010;49:2581–7.CrossRefPubMed
15.
Rowe JB, Hughes LE, Barker RA, Owen AM. Dynamic causal modelling of effective connectivity from fMRI: are results reproducible and sensitive to Parkinson’s disease and its treatment? Neuroimage. 2010;52:1015–26.CrossRefPubMedPubMedCentral
16.
Deiber MP, Passingham RE, Colebatch JG, Friston KJ, Nixon PD, Frackowiak RS. Cortical areas and the selection of movement: a study with positron emission tomography. Exp Brain Res. 1991;84:393–402.CrossRefPubMed
17.
Cunnington R, Windischberger C, Deecke L, Moser E. The preparation and execution of self-initiated and externally-triggered movement: a study of event-related fMRI. Neuroimage. 2002;15:373–85.CrossRefPubMed
18.
Jenkins IH, Jahanshahi M, Jueptner M, Passingham RE, Brooks DJ. Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow. Brain. 2000;123(Pt 6):1216–28.CrossRefPubMed
19.
Schell GR, Strick PL. The origin of thalamic inputs to the arcuate premotor and supplementary motor areas. J Neurosci. 1984;4:539–60.PubMed
20.
Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, Schwaiger M, Conrad B, Ceballos-Baumann AO. Event-related functional magnetic resonance imaging in Parkinson’s disease before and after levodopa. Brain. 2001;124:558–70.CrossRefPubMed
21.
Buhmann C, Glauche V, Sturenburg HJ, Oechsner M, Weiller C, Buchel C. Pharmacologically modulated fMRI--cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain. 2003;126:451–61.CrossRefPubMed
22.
Wu T, Hallett M, Chan P. Motor automaticity in Parkinson’s disease. Neurobiol Dis. 2015;82:226–34.CrossRefPubMed
23.
Bernstein ME, Hughes FW, Forney RB. The influence of a new chlordiazepoxide analogue on human mental and motor performance. J Clin Pharmacol J New Drugs. 1967;7:330–5.CrossRefPubMed
24.
Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA. Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nat Rev Neurosci. 2010;11:760–72.CrossRefPubMedPubMedCentral
25.
Wu T, Kansaku K, Hallett M. How self-initiated memorized movements become automatic: a functional MRI study. J Neurophysiol. 2004;91:1690–8.CrossRefPubMed
26.
Wu T, Hallett M. Neural correlates of dual task performance in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2008;79:760–6.CrossRefPubMed
27.
Wu T, Zhang J, Hallett M, Feng T, Hou Y, Chan P. Neural correlates underlying micrographia in Parkinson’s disease. Brain. 2016;139:144–60.CrossRefPubMed
28.
Wu T, Hallett M. A functional MRI study of automatic movements in patients with Parkinson’s disease. Brain. 2005;128:2250–9.CrossRefPubMed
29.
Wu T, Liu J, Zhang H, Hallett M, Zheng Z, Chan P. Attention to Automatic Movements in Parkinson’s Disease: Modified Automatic Mode in the Striatum. Cereb Cortex. 2015;25:3330–42.CrossRefPubMed
30.
Ma H, Chen H, Fang J, Gao L, Ma L, Wu T, Hou Y, Zhang J, Feng T. Resting-state functional connectivity of dentate nucleus is associated with tremor in Parkinson’s disease. J Neurol. 2015;262:2247–56.CrossRefPubMed
31.
Surdhar I, Gee M, Bouchard T, Coupland N, Malykhin N, Camicioli R. Intact limbic-prefrontal connections and reduced amygdala volumes in Parkinson’s disease with mild depressive symptoms. Parkinsonism Relat Disord. 2012;18:809–13.CrossRefPubMed
32.
Tessitore A, Amboni M, Esposito F, Russo A, Picillo M, Marcuccio L, Pellecchia MT, Vitale C, Cirillo M, Tedeschi G, Barone P. Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait. Parkinsonism Relat Disord. 2012;18:781–7.CrossRefPubMed
33.
Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol. 2011;10:734–44.CrossRefPubMed
34.
Liu H, Edmiston EK, Fan G, Xu K, Zhao B, Shang X, Wang F. Altered resting-state functional connectivity of the dentate nucleus in Parkinson’s disease. Psychiatry Res. 2013;211:64–71.CrossRefPubMed
35.
Hu X, Zhang J, Jiang X, Zhou C, Wei L, Yin X, Wu Y, Li J, Zhang Y, Wang J. Decreased interhemispheric functional connectivity in subtypes of Parkinson’s disease. J Neurol. 2015;262:760–7.CrossRefPubMed
36.
Seibert TM, Murphy EA, Kaestner EJ, Brewer JB. Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging. Radiology. 2012;263:226–34.CrossRefPubMedPubMedCentral
37.
Gorges M, Muller HP, Lule D, Pinkhardt EH, Ludolph AC, Kassubek J. To rise and to fall: functional connectivity in cognitively normal and cognitively impaired patients with Parkinson’s disease. Neurobiol Aging. 2015;36:1727–35.CrossRefPubMed
38.
Disbrow EA, Carmichael O, He J, Lanni KE, Dressler EM, Zhang L, Malhado-Chang N, Sigvardt KA. Resting state functional connectivity is associated with cognitive dysfunction in non-demented people with Parkinson’s disease. J Parkinsons Dis. 2014;4:453–65.PubMed
39.
Salvador R, Suckling J, Coleman MR, Pickard JD, Menon D, Bullmore E. Neurophysiological architecture of functional magnetic resonance images of human brain. Cereb Cortex. 2005;15:1332–42.CrossRefPubMed
40.
Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A. 2003;100:253–8.CrossRefPubMed
41.
Manza P, Zhang S, Li CS, Leung HC. Resting-state functional connectivity of the striatum in early-stage Parkinson’s disease: Cognitive decline and motor symptomatology. Hum Brain Mapp. 2016;37:648–62.CrossRefPubMed
42.
Luo C, Chen Q, Song W, Chen K, Guo X, Yang J, Huang X, Gong Q, Shang HF. Resting-state fMRI study on drug-naive patients with Parkinson’s disease and with depression. J Neurol Neurosurg Psychiatry. 2014;85:675–83.CrossRefPubMed
43.
Hu X, Song X, Li E, Liu J, Yuan Y, Liu W, Liu Y. Altered Resting-State Brain Activity and Connectivity in Depressed Parkinson’s Disease. PLoS One. 2015;10:e131133.
44.
Taylor KS, Seminowicz DA, Davis KD. Two systems of resting state connectivity between the insula and cingulate cortex. Hum Brain Mapp. 2009;30:2731–45.CrossRefPubMed
45.
46.
Sunwoo MK, Cha J, Ham JH, Song SK, Hong JY, Lee JM, Sohn YH, Lee PH. Olfactory performance and resting state functional connectivity in non-demented drug naive patients with Parkinson’s disease. Hum Brain Mapp. 2015;36:1716–27.CrossRefPubMed
47.
Baggio HC, Segura B, Garrido-Millan JL, Marti MJ, Compta Y, Valldeoriola F, Tolosa E, Junque C. Resting-state frontostriatal functional connectivity in Parkinson’s disease-related apathy. Mov Disord. 2015;30:671–9.CrossRefPubMed
48.
Yao N, Pang S, Cheung C, Chang RS, Lau KK, Suckling J, Yu K, Mak HK, McAlonan G, Ho SL, Chua SE. Resting activity in visual and corticostriatal pathways in Parkinson’s disease with hallucinations. Parkinsonism Relat Disord. 2015;21:131–7.CrossRefPubMed
49.
Meppelink AM, de Jong BM, Renken R, Leenders KL, Cornelissen FW, van Laar T. Impaired visual processing preceding image recognition in Parkinson’s disease patients with visual hallucinations. Brain. 2009;132:2980–93.CrossRefPubMed
50.
Kwak Y, Peltier S, Bohnen NI, Muller ML, Dayalu P, Seidler RD. Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson’s disease. Front Syst Neurosci. 2010;4:143.CrossRefPubMedPubMedCentral
51.
Agosta F, Caso F, Stankovic I, Inuggi A, Petrovic I, Svetel M, Kostic VS, Filippi M. Cortico-striatal-thalamic network functional connectivity in hemiparkinsonism. Neurobiol Aging. 2014;35:2592–602.CrossRefPubMed
52.
Bell PT, Gilat M, O’Callaghan C, Copland DA, Frank MJ, Lewis SJ, Shine JM. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson’s disease. Hum Brain Mapp. 2015;36:1278–91.CrossRefPubMed
53.
Szewczyk-Krolikowski K, Menke RA, Rolinski M, Duff E, Salimi-Khorshidi G, Filippini N, Zamboni G, Hu MT, Mackay CE. Functional connectivity in the basal ganglia network differentiates PD patients from controls. Neurology. 2014;83:208–14.CrossRefPubMedPubMedCentral
54.
Herz DM, Haagensen BN, Christensen MS, Madsen KH, Rowe JB, Lokkegaard A, Siebner HR. Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans. Brain. 2015;138:1658–66.CrossRefPubMedPubMedCentral
55.
Herz DM, Haagensen BN, Nielsen SH, Madsen KH, Lokkegaard A, Siebner HR. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson’s disease. Mov Disord. 2016;31:521–9.CrossRefPubMed
56.
Cerasa A, Donzuso G, Morelli M, Mangone G, Salsone M, Passamonti L, Augimeri A, Arabia G, Quattrone A. The motor inhibition system in Parkinson’s disease with levodopa-induced dyskinesias. Mov Disord. 2015;30:1912–20.CrossRefPubMed
57.
Kahan J, Urner M, Moran R, Flandin G, Marreiros A, Mancini L, White M, Thornton J, Yousry T, Zrinzo L, et al. Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on ‘effective’ connectivity. Brain. 2014;137:1130–44.CrossRefPubMedPubMedCentral
58.
Schweder PM, Joint C, Hansen PC, Green AL, Quaghebeur G, Aziz TZ. Chronic pedunculopontine nucleus stimulation restores functional connectivity. Neuroreport. 2010;21:1065–8.CrossRefPubMed
59.
Long D, Wang J, Xuan M, Gu Q, Xu X, Kong D, Zhang M. Automatic classification of early Parkinson’s disease with multi-modal MR imaging. PLoS One. 2012;7:e47714.CrossRefPubMedPubMedCentral
60.
Skidmore FM, Yang M, Baxter L, von Deneen KM, Collingwood J, He G, White K, Korenkevych D, Savenkov A, Heilman KM, et al. Reliability analysis of the resting state can sensitively and specifically identify the presence of Parkinson disease. Neuroimage. 2013;75:249–61.CrossRefPubMed
61.
Wu T, Ma Y, Zheng Z, Peng S, Wu X, Eidelberg D, Chan P. Parkinson’s disease-related spatial covariance pattern identified with resting-state functional MRI. J Cereb Blood Flow Metab. 2015;35:1764–70.CrossRefPubMed
Metadata
Title
The study of brain functional connectivity in Parkinson’s disease
Authors
Lin-lin Gao
Tao Wu
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Translational Neurodegeneration / Issue 1/2016
Electronic ISSN: 2047-9158
DOI
https://doi.org/10.1186/s40035-016-0066-0

Other articles of this Issue 1/2016

Translational Neurodegeneration 1/2016 Go to the issue

Review

7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders

Research

miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study

Review

Mitochondrial dysfunction in Parkinson’s disease

Research

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Research

A survey of impulse control disorders in Parkinson’s disease patients in Shanghai area and literature review

Research

The predictive value of SS-16 in clinically diagnosed Parkinson’s disease patients: comparison with 99mTc-TRODAT-1 SPECT scans